Effect of Stem-Kine Food Supplement on Circulating Stem Cells
Completed
- Conditions
- Healthy VolunteersNutritional, Metabolic, Endocrine
- Registration Number
- ISRCTN25688299
- Lead Sponsor
- Medistem Inc (USA)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 18
Inclusion Criteria
1. Healthy adults, ages 20-72
2. Signed informed consent
Exclusion Criteria
1. Systemic immune-compromised state
2. Ongoing infection or disease conditions
3. Significant abnormalities in biochemistry or complete blood count panels
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Alteration in circulating hematopoietic and endothelial progenitor cells. <br>Blood samples taken pre-supplementation (day 0), and at days 1, 2, 7, and 14 are analyzed by flow cytometry and colony forming assays
- Secondary Outcome Measures
Name Time Method Changes in overall health/mood, based on self reporting
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways does Stem-Kine modulate to influence circulating stem cell mobilization in healthy volunteers?
How does Stem-Kine compare to standard nutritional interventions in enhancing endogenous stem cell populations?
Are there specific biomarkers that correlate with increased CD34+ cell levels following Stem-Kine supplementation?
What adverse effects are associated with long-term Stem-Kine use in metabolic/endocrine health contexts?
What combination therapies or competitor supplements target similar stem cell mobilization mechanisms as Stem-Kine?